Analisis Efektifitas Biaya Terapi Pengobatan Pasien Diabetes Mellitus Tipe 2 terhadap Kontrol Glukosa Darah

Diabetes mellitus (DM) is a chronic disease characterized by blood glucose levels exceeding normal. The length of therapy in DM patients causes the large amount treatment costs incurred, although Indonesia BPJS insurance used but this puts burden health financing on Indonesian government, so there need for an analysis associated with therapeutic outcomes. purpose study was to analyze Cost Effectiveness Type 2 hospital South Surabaya area. method observation, retrospective observation type outpatient internal polyclinics period April – December 2021. results obtained were 30 who routinely controlled 2, 3, 4, 5, 6, 7, 8 and 9 months, receiving single or combination antidiabetic drugs. In study, cost effectiveness carried out measurement outcomes, namely pre-post GDP GD2PP. conclusion female (100%), age > 45 years 24 people (80%). sulfonylurea 50% ACER between Rp. 4,392.48 18,686.86 routine control 3 months. For combinations Thiazolidinediones + Insulin has value 100% 42,490.08 6 While that have are Sulfonylurea Thiazolidinedione Biguanide price 6,668.4 follow-up oral insulin (Insulin Thiazolidioine alpha glucosidase inhibitor) value, 36,082.36 7